Constanza Vargas

Level 5, Building 20, 100 Broadway, Broadway, PO Box 123
Sydney, NSW 2007, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Societal Preferences for Assessment Pathways of Rare Disease Drugs: A Discrete Choice Experiment.

Societal Preferences for Assessment Pathways of Rare Disease Drugs: A Discrete Choice Experiment.

Journal: Applied health economics and health policy

Published: February 04, 2026

In Reply to Meng et al.

In Reply to Meng et al.

Journal: International journal of radiation oncology, biology, physics

Published: July 25, 2025

Using a discrete choice experiments to explore societal preferences for valuing new drugs for rare diseases.

Using a discrete choice experiments to explore societal preferences for valuing new drugs for rare diseases.

Journal: Orphanet journal of rare diseases

Published: May 13, 2025

Correction: Systematic Literature Review of Access Pathways to Drugs for Patients with Rare Diseases.

Correction: Systematic Literature Review of Access Pathways to Drugs for Patients with Rare Diseases.

Journal: Applied health economics and health policy

Published: March 21, 2025

SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial.

SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial.

Journal: International journal of radiation oncology, biology, physics

Published: December 10, 2024

Systematic Literature Review of Access Pathways to Drugs for Patients with Rare Diseases.

Systematic Literature Review of Access Pathways to Drugs for Patients with Rare Diseases.

Journal: Applied health economics and health policy

Published: December 08, 2024

Use of Health Technology Assessment for the Continued Funding of Health Technologies: The Case of Immunoglobulins for the Management of Multifocal Motor Neuropathy.

Use of Health Technology Assessment for the Continued Funding of Health Technologies: The Case of Immunoglobulins for the Management of Multifocal Motor Neuropathy.

Journal: Applied health economics and health policy

Published: October 29, 2023

Challenges for gene therapy in the financial sustainability of health systems: a scoping review.

Challenges for gene therapy in the financial sustainability of health systems: a scoping review.

Journal: Orphanet journal of rare diseases

Published: August 03, 2023

An analysis of the resource use and costs of febrile neutropenia events in pediatric cancer patients in Australia.

An analysis of the resource use and costs of febrile neutropenia events in pediatric cancer patients in Australia.

Journal: Pediatric blood & cancer

Published: April 27, 2023

Association between antimicrobial resistance and biofilm forming ability of Salmonella enterica serotypes from commercial broiler farms in Brazil.

Association between antimicrobial resistance and biofilm forming ability of Salmonella enterica serotypes from commercial broiler farms in Brazil.

Journal: British poultry science

Published: October 19, 2022

Medication review with follow-up for cardiovascular outcomes: a trial based cost-utility analysis.

Medication review with follow-up for cardiovascular outcomes: a trial based cost-utility analysis.

Journal: Journal of comparative effectiveness research

Published: February 05, 2021

Cost-utility analysis of medication review with follow-up for cardiovascular outcomes: A microsimulation model.

Cost-utility analysis of medication review with follow-up for cardiovascular outcomes: A microsimulation model.

Journal: Health policy (Amsterdam, Netherlands)

Published: December 14, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026